Search results

Richmond Research Institute asks the question, 'Can a second booster dose be delayed in patients who have COVID-19?'
www.richmondresearchinstitute.org/news/richmond-research-institute-asks-the-question-do-post-covid-19-patients-need-a-second-dose-of-vaccine

In the UK, two vaccines (BNT162b2-mRNA produced by Pfizer, and ChAdOx-1-S produced by Oxford-AstraZeneca) have been licensed to date, and their administration is prioritised according to individual risk.

COVID-19 Testing - Richmond Research Institute
www.richmondresearchinstitute.org/covid-19/testing

We have also continued to test for antibodies to both infection and vaccine. By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity may last in each person.

Home video
www.richmondresearchinstitute.org/dev/home-video

Do post-COVID-19 patients need a second dose of vaccine? Individuals who were previously infected produced significantly more antibodies, more rapidly. This data could inform prioritisation of vaccine administration. COVID-19 Testing.

Home - Richmond Research Institute
www.richmondresearchinstitute.org/

This information could inform the prioritisation of vaccine administration. Watch the video below to learn more.

We work with partners at the following organisations: 

richmond research institute

We have a track record in conducting clinical research.

Publications

We present our scientific findings at meetings.

Videos

Our academic research helps improve lives and strengthens scientific insights.

Research